Provided by Tiger Fintech (Singapore) Pte. Ltd.

Surmodics

29.87
+0.71002.43%
Post-market: 29.870.00000.00%16:04 EDT
Volume:51.74K
Turnover:1.53M
Market Cap:427.12M
PE:-21.36
High:29.87
Open:29.16
Low:28.89
Close:29.16
Loading ...

Surmodics Outlook FY Adj EPS $-0.62 to $-0.42

THOMSON REUTERS
·
30 Apr

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance

Business Wire
·
30 Apr

SurModics Inc. to Release Financial Results for Second Quarter of Fiscal 2025

Reuters
·
29 Apr

Press Release: Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30

Dow Jones
·
29 Apr

Surmodics publishes TRANSCEND trial data

TIPRANKS
·
22 Apr

Barrington Sticks to Their Hold Rating for SurModics (SRDX)

TIPRANKS
·
04 Apr

Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries

Business Wire
·
03 Apr

SRDX Stock Falls Following Plan for Legal Action Against FTC Challenge

Zacks
·
08 Mar

Lake Street Upgrades SurModics to Buy From Hold, Price Target is $43

MT Newswires Live
·
07 Mar

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Mind Medicine (MNMD), SurModics (SRDX) and Enhabit, Inc (EHAB)

TIPRANKS
·
07 Mar

Surmodics upgraded to Buy from Hold at Lake Street

TIPRANKS
·
07 Mar

Surmodics Vows to Oppose FTC Decision to Block GTCR Deal

MT Newswires Live
·
07 Mar

BRIEF-Surmodics Says Disagrees With FTC's Decision And Remains Committed To Completing Merger with GTCR

Reuters
·
07 Mar

Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated With Gtcr

THOMSON REUTERS
·
07 Mar

Surmodics Inc - Defend This Case in Court in Order to Complete Merger.

THOMSON REUTERS
·
07 Mar

Surmodics Inc - Respectfully Disagrees With FTC's Decision and Remains Committed to Completing Merger

THOMSON REUTERS
·
07 Mar

Surmodics Inc - Remains Confident in Both Its Rationale for Merger

THOMSON REUTERS
·
07 Mar

Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR

Business Wire
·
07 Mar

US FTC sues to block private equity purchase of medical company

Reuters
·
07 Mar

Surmodics Inc Shares Lose Ground Sharply With Volume Spike, Last Down 3.6% at $29.90

THOMSON REUTERS
·
07 Mar